Home
Conditions
Adenocarcinoma

Clinical trial condition

Adenocarcinoma

Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.

5,072 public trials 1,188 recruiting studies

Refine in advanced search Browse all conditions

Adenocarcinoma trial results

Not yet recruiting

A Phase II Study of GV20-0251 in Combination With Anti-PD-1 Monoclonal Antibodies in Patients With Unresectable, Locally Advanced, or Metastatic Solid Tumors.

NCT07623642

Conditions: Adenocarcinoma, Biliary Tract Diseases, Biliary Tract Neoplasms, +55 more
Locations: Beijing Cancer Hospital Beijing, Beijing Municipality, China

Harbin Medical University Cancer Hospital Harbin, Heilongjiang, China

View Trial Details

Not yet recruiting

CLINICAL STUDY TO IDENTIFY BIOMARKERS FOR TUMOR SPREAD THROUGH AIR SPACES STATUS

NCT07630246

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Carcinoma, +10 more
Locations: NMS Research | Cancer Nanomedicine - João Conde's Lab Lisbon, Portugal

Unidade Local de Saúde de São José Lisbon, Portugal

View Trial Details

Not yet recruiting

Liver Transplant for Hepatocellular Carcinoma

NCT07629193

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
Locations: Not specified

View Trial Details

Not yet recruiting

Anlotinib + Benmelstobart vs Surgery for Patients With Localized Renal Cell Carcinoma Scheduled to Undergo Partial Nephrectomy

NCT07627464

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Peking University Third Hospital Beijing, China

Jilin Provincial Cancer Hospital Changchun, China

Hunan Provincial Cancer Hospital Changsha, China

The First Affiliated Hospital, Zhejiang University School of Medicine Hangzhou, China

View all 14 locations

View Trial Details

Not yet recruiting

Epalrestat Combined With HAIC, Donafenib and Tislelizumab as First-line Treatment for Patients With Unresectable HCC and Diabetes

NCT07557914

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +15 more
Locations: The First Hospital of China Medical University Shenyang, Liaoning, China

View Trial Details

Not yet recruiting

A Comparison of [68Ga]DOTATATE and [18F]AmBF3TATE for the Staging and Assessment of Neuroendocrine Malignancies

NCT07621146

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +15 more
Locations: BC Cancer Vancouver Vancouver, British Columbia, Canada

View Trial Details

Not yet recruiting

EYEMAX® Versus SPYGLASS™ DS for Biliary Stricture Diagnosis

NCT07620080

Conditions: Adenocarcinoma, Biliary Stricture, Carcinoma, +4 more
Locations: Not specified

View Trial Details

Not yet recruiting

Clinical Utility of Preoperative Thyroid GuidePx® Testing

NCT07584447

Conditions: Adenocarcinoma, Adenocarcinoma, Papillary, Carcinoma, +12 more
Locations: Not specified

View Trial Details

Not yet recruiting

A Multicenter, Randomized, Open-label, Controlled Study of HAIC Combined With Camrelizumab and Apatinib Mesylate for Perioperative Treatment of Resectable Hepatocellular Carcinoma With High-risk Recurrence Factors

NCT07618546

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Not specified

View Trial Details

Not yet recruiting

Neoadjuvant Anlotinib and Epirubicin for T4 Sinonasal Adenoid Cystic Carcinoma

NCT07616141

Conditions: Adenocarcinoma, Adenoid Cystic Carcinoma, Carcinoma, +4 more
Locations: Xuanwu Hospital, Capital Medical University Beijing, Beijing Municipality, China

The Third Affiliated Hospital of Sun Yat-sen University Guangzhou, Guangdong, China

The Affiliated Hospital of Qingdao University Qingdao, Shandong, China

Zhongshan Hospital, Fudan University Shanghai, Shanghai Municipality, China

View Trial Details

Adenocarcinoma

Adenocarcinoma trial results

Related conditions